Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.81164757 |
2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.89796298 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.89176171 |
4 | negative regulation of cell killing (GO:0031342) | 4.89176171 |
5 | detection of other organism (GO:0098543) | 4.76798892 |
6 | detection of bacterium (GO:0016045) | 4.63911179 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.55646940 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.55646940 |
9 | modulation by symbiont of host immune response (GO:0052553) | 4.55646940 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.55646940 |
11 | modulation by symbiont of host defense response (GO:0052031) | 4.55646940 |
12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.55646940 |
13 | leukocyte aggregation (GO:0070486) | 4.53082436 |
14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.42352964 |
15 | B cell receptor signaling pathway (GO:0050853) | 4.33776136 |
16 | positive thymic T cell selection (GO:0045059) | 4.26493407 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26451814 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26451814 |
19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.20497941 |
20 | neutrophil activation involved in immune response (GO:0002283) | 4.16329612 |
21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.11031503 |
22 | response to peptidoglycan (GO:0032494) | 4.08309220 |
23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.03302028 |
24 | detection of external biotic stimulus (GO:0098581) | 4.01097539 |
25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98987345 |
26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.95939949 |
27 | positive regulation of B cell differentiation (GO:0045579) | 3.95434870 |
28 | neutrophil activation (GO:0042119) | 3.94569400 |
29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93481254 |
30 | regulation of B cell differentiation (GO:0045577) | 3.90931976 |
31 | macrophage activation involved in immune response (GO:0002281) | 3.82879795 |
32 | negative thymic T cell selection (GO:0045060) | 3.81682108 |
33 | negative T cell selection (GO:0043383) | 3.80389890 |
34 | mature B cell differentiation (GO:0002335) | 3.79088634 |
35 | histone H3-K4 trimethylation (GO:0080182) | 3.77805616 |
36 | response to muramyl dipeptide (GO:0032495) | 3.76133314 |
37 | detection of molecule of bacterial origin (GO:0032490) | 3.75090635 |
38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.75026713 |
39 | respiratory burst (GO:0045730) | 3.68485460 |
40 | positive T cell selection (GO:0043368) | 3.68340262 |
41 | T cell migration (GO:0072678) | 3.67558305 |
42 | tolerance induction (GO:0002507) | 3.66577850 |
43 | granulocyte activation (GO:0036230) | 3.64915440 |
44 | immunoglobulin mediated immune response (GO:0016064) | 3.62100144 |
45 | cellular extravasation (GO:0045123) | 3.61970704 |
46 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61318268 |
47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.60410317 |
48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.59362462 |
49 | NIK/NF-kappaB signaling (GO:0038061) | 3.57616459 |
50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56496663 |
51 | detection of biotic stimulus (GO:0009595) | 3.51833257 |
52 | neutrophil mediated immunity (GO:0002446) | 3.47048631 |
53 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.45461846 |
54 | positive regulation of interferon-alpha production (GO:0032727) | 3.44541131 |
55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.44418377 |
56 | interferon-gamma production (GO:0032609) | 3.42652973 |
57 | germinal center formation (GO:0002467) | 3.40262812 |
58 | thymic T cell selection (GO:0045061) | 3.33636522 |
59 | negative regulation of granulocyte differentiation (GO:0030853) | 3.32040939 |
60 | myeloid cell activation involved in immune response (GO:0002275) | 3.29653715 |
61 | regulation of interferon-alpha production (GO:0032647) | 3.28698660 |
62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.28563955 |
63 | T cell selection (GO:0045058) | 3.28080723 |
64 | response to interleukin-15 (GO:0070672) | 3.27748057 |
65 | B cell homeostasis (GO:0001782) | 3.27503530 |
66 | cellular response to interleukin-15 (GO:0071350) | 3.25306276 |
67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24845373 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23515769 |
69 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.22512588 |
70 | regulation of leukocyte degranulation (GO:0043300) | 3.22270202 |
71 | negative regulation of interleukin-12 production (GO:0032695) | 3.20421285 |
72 | response to host immune response (GO:0052572) | 3.20118674 |
73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.20118674 |
74 | B cell mediated immunity (GO:0019724) | 3.18396238 |
75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.17939417 |
76 | regulation of tolerance induction (GO:0002643) | 3.16766170 |
77 | regulation of T cell tolerance induction (GO:0002664) | 3.16568532 |
78 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.14876463 |
79 | regulation of antigen processing and presentation (GO:0002577) | 3.13445266 |
80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13382252 |
81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11919379 |
82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10786950 |
83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08287797 |
84 | defense response to protozoan (GO:0042832) | 3.07095710 |
85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06512447 |
86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04932300 |
87 | I-kappaB phosphorylation (GO:0007252) | 3.04893565 |
88 | activated T cell proliferation (GO:0050798) | 3.02861440 |
89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99725623 |
90 | microglial cell activation (GO:0001774) | 2.98928680 |
91 | mature B cell differentiation involved in immune response (GO:0002313) | 2.98738274 |
92 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98491437 |
93 | leukocyte cell-cell adhesion (GO:0007159) | 2.97583842 |
94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96972517 |
95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95613371 |
96 | leukocyte degranulation (GO:0043299) | 2.94442127 |
97 | negative regulation of interleukin-6 production (GO:0032715) | 2.94076595 |
98 | negative regulation of innate immune response (GO:0045824) | 2.93759093 |
99 | response to host (GO:0075136) | 2.93733427 |
100 | response to host defenses (GO:0052200) | 2.93733427 |
101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93733427 |
102 | negative regulation of phagocytosis (GO:0050765) | 2.93700360 |
103 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93534356 |
104 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93534356 |
105 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91321615 |
106 | mast cell activation (GO:0045576) | 2.91167463 |
107 | response to type I interferon (GO:0034340) | 2.90920724 |
108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90406322 |
109 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89749936 |
110 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.87177075 |
111 | response to protozoan (GO:0001562) | 2.86292123 |
112 | modulation by symbiont of host cellular process (GO:0044068) | 2.86259027 |
113 | myeloid dendritic cell activation (GO:0001773) | 2.85055816 |
114 | cellular response to type I interferon (GO:0071357) | 2.84790140 |
115 | type I interferon signaling pathway (GO:0060337) | 2.84790140 |
116 | lymphocyte homeostasis (GO:0002260) | 2.84556026 |
117 | regulation of mast cell degranulation (GO:0043304) | 2.82387302 |
118 | regulation of mast cell activation (GO:0033003) | 2.81243826 |
119 | pinocytosis (GO:0006907) | 2.80342390 |
120 | B cell proliferation (GO:0042100) | 2.79790349 |
121 | modulation by virus of host process (GO:0019054) | 2.79620057 |
122 | negative regulation of B cell proliferation (GO:0030889) | 2.79134973 |
123 | regulation of B cell proliferation (GO:0030888) | 2.78430160 |
124 | cellular response to zinc ion (GO:0071294) | 2.78181425 |
125 | positive regulation of mast cell activation (GO:0033005) | 2.75579758 |
126 | macrophage activation (GO:0042116) | 2.75255626 |
127 | regulation of granulocyte differentiation (GO:0030852) | 2.74672652 |
128 | positive regulation of B cell proliferation (GO:0030890) | 2.73417960 |
129 | T cell receptor signaling pathway (GO:0050852) | 2.72368830 |
130 | positive regulation of interleukin-2 production (GO:0032743) | 2.72332513 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.61421365 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.37536921 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.00803104 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.81353958 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.87739606 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.84768966 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.82026084 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.78158024 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75601337 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.36315465 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.07241621 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05945194 |
13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01028332 |
14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.87673111 |
15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.87196367 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.85193244 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.84636049 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69807018 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66910984 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58092593 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55135098 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.44948304 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.42826395 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 2.38849088 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.25220539 |
26 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.23155932 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23055285 |
28 | MYB_26560356_Chip-Seq_TH1_Human | 2.22290100 |
29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18139306 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14572727 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11733720 |
32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01317957 |
33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99822834 |
34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94835970 |
35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92728531 |
36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.87059894 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84721457 |
38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78799722 |
39 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73134733 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72025898 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71550612 |
42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68816132 |
43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65509987 |
44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63925825 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59497528 |
46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48966775 |
47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47754362 |
48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47011503 |
49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46972639 |
50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46913587 |
51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44143090 |
52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44127072 |
53 | MAF_26560356_Chip-Seq_TH2_Human | 1.41796109 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39800899 |
55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38550511 |
56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38374690 |
57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36597058 |
58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34037922 |
59 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33383154 |
60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31401122 |
61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31162362 |
62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29613652 |
63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26835634 |
64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23339482 |
65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23287898 |
66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23032112 |
67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22370876 |
68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22124667 |
69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20249654 |
70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20018732 |
71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18443882 |
72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18197520 |
73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16896419 |
74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16823722 |
75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16164131 |
76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12996822 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08820507 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07754132 |
79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07353436 |
80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06751644 |
81 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03596750 |
82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00887973 |
83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99775993 |
84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99570086 |
85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98938647 |
86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98169086 |
87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97945268 |
88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94516737 |
89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94411696 |
90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92231822 |
91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90360724 |
92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88215580 |
93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87001436 |
94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86811734 |
95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86466672 |
96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86147824 |
97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84915357 |
98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84682816 |
99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83106456 |
100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83082088 |
101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82749207 |
102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81910515 |
103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81665398 |
104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79056551 |
105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78674120 |
106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73682774 |
107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.68074996 |
108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67218069 |
109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.67209789 |
110 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.63850393 |
111 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.62463673 |
112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61623582 |
113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.61192338 |
114 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.59836759 |
115 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.59210124 |
116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58734299 |
117 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.57705951 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.49091560 |
2 | MP0001790_abnormal_immune_system | 3.40090069 |
3 | MP0005387_immune_system_phenotype | 3.40090069 |
4 | MP0001800_abnormal_humoral_immune | 3.30299606 |
5 | MP0005671_abnormal_response_to | 3.22825515 |
6 | MP0000569_abnormal_digit_pigmentation | 3.13767298 |
7 | MP0003303_peritoneal_inflammation | 3.09483823 |
8 | MP0003436_decreased_susceptibility_to | 2.99553803 |
9 | MP0005000_abnormal_immune_tolerance | 2.98469535 |
10 | MP0002452_abnormal_antigen_presenting | 2.96326315 |
11 | MP0000685_abnormal_immune_system | 2.95129842 |
12 | MP0002419_abnormal_innate_immunity | 2.83869677 |
13 | MP0002723_abnormal_immune_serum | 2.76108874 |
14 | MP0002420_abnormal_adaptive_immunity | 2.70416266 |
15 | MP0001819_abnormal_immune_cell | 2.67987339 |
16 | MP0009785_altered_susceptibility_to | 2.60312769 |
17 | MP0005025_abnormal_response_to | 2.58033744 |
18 | MP0003763_abnormal_thymus_physiology | 2.57973289 |
19 | MP0003183_abnormal_peptide_metabolism | 2.54792836 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.47553770 |
21 | MP0005174_abnormal_tail_pigmentation | 2.37397275 |
22 | MP0002398_abnormal_bone_marrow | 2.28711266 |
23 | MP0002396_abnormal_hematopoietic_system | 2.28147536 |
24 | MP0005464_abnormal_platelet_physiology | 2.25640405 |
25 | MP0000716_abnormal_immune_system | 2.16647882 |
26 | MP0002405_respiratory_system_inflammati | 2.15554089 |
27 | MP0004510_myositis | 2.15495273 |
28 | MP0006082_CNS_inflammation | 2.11389970 |
29 | MP0003172_abnormal_lysosome_physiology | 2.07402255 |
30 | MP0002166_altered_tumor_susceptibility | 2.06929834 |
31 | MP0005058_abnormal_lysosome_morphology | 1.97351114 |
32 | MP0003300_gastrointestinal_ulcer | 1.94921472 |
33 | MP0000015_abnormal_ear_pigmentation | 1.93504743 |
34 | MP0000689_abnormal_spleen_morphology | 1.92901988 |
35 | MP0001873_stomach_inflammation | 1.85038068 |
36 | MP0002006_tumorigenesis | 1.80689324 |
37 | MP0002722_abnormal_immune_system | 1.80617472 |
38 | MP0002429_abnormal_blood_cell | 1.72287183 |
39 | MP0005451_abnormal_body_composition | 1.71475183 |
40 | MP0009278_abnormal_bone_marrow | 1.70709225 |
41 | MP0001845_abnormal_inflammatory_respons | 1.67961488 |
42 | MP0010155_abnormal_intestine_physiology | 1.67398389 |
43 | MP0009333_abnormal_splenocyte_physiolog | 1.66710346 |
44 | MP0003724_increased_susceptibility_to | 1.60578976 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.60101256 |
46 | MP0004808_abnormal_hematopoietic_stem | 1.57459391 |
47 | MP0000703_abnormal_thymus_morphology | 1.56977838 |
48 | MP0004947_skin_inflammation | 1.52886214 |
49 | MP0001853_heart_inflammation | 1.52655356 |
50 | MP0005310_abnormal_salivary_gland | 1.48726125 |
51 | MP0001533_abnormal_skeleton_physiology | 1.45374683 |
52 | MP0003787_abnormal_imprinting | 1.41108224 |
53 | MP0002933_joint_inflammation | 1.37028761 |
54 | MP0003866_abnormal_defecation | 1.34337366 |
55 | MP0003075_altered_response_to | 1.22616637 |
56 | MP0008469_abnormal_protein_level | 1.18432861 |
57 | MP0004883_abnormal_blood_vessel | 1.17460160 |
58 | MP0005397_hematopoietic_system_phenotyp | 1.16669948 |
59 | MP0001545_abnormal_hematopoietic_system | 1.16669948 |
60 | MP0002998_abnormal_bone_remodeling | 1.15674942 |
61 | MP0001851_eye_inflammation | 1.14400494 |
62 | MP0003448_altered_tumor_morphology | 1.14309982 |
63 | MP0003045_fibrosis | 1.13233448 |
64 | MP0000490_abnormal_crypts_of | 1.12143361 |
65 | MP0002095_abnormal_skin_pigmentation | 1.09126816 |
66 | MP0005075_abnormal_melanosome_morpholog | 1.07946348 |
67 | MP0002277_abnormal_respiratory_mucosa | 1.05954885 |
68 | MP0000858_altered_metastatic_potential | 1.03736138 |
69 | MP0004381_abnormal_hair_follicle | 1.02426745 |
70 | MP0005409_darkened_coat_color | 0.98350972 |
71 | MP0009840_abnormal_foam_cell | 0.96929214 |
72 | MP0000604_amyloidosis | 0.95967363 |
73 | MP0009764_decreased_sensitivity_to | 0.90486041 |
74 | MP0002138_abnormal_hepatobiliary_system | 0.89793316 |
75 | MP0001986_abnormal_taste_sensitivity | 0.89124406 |
76 | MP0000371_diluted_coat_color | 0.89103952 |
77 | MP0005164_abnormal_response_to | 0.88372686 |
78 | MP0008004_abnormal_stomach_pH | 0.88008411 |
79 | MP0002928_abnormal_bile_duct | 0.85501973 |
80 | MP0003191_abnormal_cellular_cholesterol | 0.84389597 |
81 | MP0010307_abnormal_tumor_latency | 0.84383395 |
82 | MP0005076_abnormal_cell_differentiation | 0.78816716 |
83 | MP0008057_abnormal_DNA_replication | 0.77748731 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 0.73908080 |
85 | MP0009765_abnormal_xenobiotic_induced | 0.70676525 |
86 | MP0005257_abnormal_intraocular_pressure | 0.70044030 |
87 | MP0008058_abnormal_DNA_repair | 0.67763338 |
88 | MP0002019_abnormal_tumor_incidence | 0.66936638 |
89 | MP0000343_altered_response_to | 0.65626592 |
90 | MP0005390_skeleton_phenotype | 0.65517190 |
91 | MP0003828_pulmonary_edema | 0.65350405 |
92 | MP0009763_increased_sensitivity_to | 0.65041742 |
93 | MP0008874_decreased_physiological_sensi | 0.64740686 |
94 | MP0008260_abnormal_autophagy | 0.63526997 |
95 | MP0003453_abnormal_keratinocyte_physiol | 0.63344030 |
96 | MP0003091_abnormal_cell_migration | 0.63216981 |
97 | MP0008961_abnormal_basal_metabolism | 0.59083787 |
98 | MP0003795_abnormal_bone_structure | 0.58391523 |
99 | MP0001663_abnormal_digestive_system | 0.57482184 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56268459 |
101 | MP0000249_abnormal_blood_vessel | 0.55229008 |
102 | MP0003806_abnormal_nucleotide_metabolis | 0.54075804 |
103 | MP0005381_digestive/alimentary_phenotyp | 0.54033388 |
104 | MP0005670_abnormal_white_adipose | 0.53834092 |
105 | MP0003690_abnormal_glial_cell | 0.53428775 |
106 | MP0003566_abnormal_cell_adhesion | 0.53108094 |
107 | MP0002132_abnormal_respiratory_system | 0.52820644 |
108 | MP0002075_abnormal_coat/hair_pigmentati | 0.50944519 |
109 | MP0002136_abnormal_kidney_physiology | 0.50746808 |
110 | MP0002009_preneoplasia | 0.48564270 |
111 | MP0001186_pigmentation_phenotype | 0.48193818 |
112 | MP0002254_reproductive_system_inflammat | 0.47981642 |
113 | MP0005319_abnormal_enzyme/_coenzyme | 0.46831739 |
114 | MP0002332_abnormal_exercise_endurance | 0.46816721 |
115 | MP0005166_decreased_susceptibility_to | 0.46551650 |
116 | MP0002693_abnormal_pancreas_physiology | 0.46416136 |
117 | MP0000609_abnormal_liver_physiology | 0.46154615 |
118 | MP0005621_abnormal_cell_physiology | 0.44977725 |
119 | MP0000767_abnormal_smooth_muscle | 0.42868333 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.77674039 |
2 | Eczematoid dermatitis (HP:0000976) | 5.27035186 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.18977561 |
4 | Recurrent fungal infections (HP:0002841) | 4.53953403 |
5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.26392674 |
6 | Recurrent cutaneous fungal infections (HP:0011370) | 4.25077294 |
7 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.25077294 |
8 | Recurrent viral infections (HP:0004429) | 4.15340852 |
9 | Agammaglobulinemia (HP:0004432) | 4.07669053 |
10 | Recurrent skin infections (HP:0001581) | 3.90200891 |
11 | Panhypogammaglobulinemia (HP:0003139) | 3.81146419 |
12 | Gastrointestinal infarctions (HP:0005244) | 3.79511584 |
13 | Obstructive lung disease (HP:0006536) | 3.71265751 |
14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.71265751 |
15 | Meningitis (HP:0001287) | 3.64207459 |
16 | Mediastinal lymphadenopathy (HP:0100721) | 3.58455801 |
17 | Abnormality of the fingertips (HP:0001211) | 3.55357241 |
18 | Inflammation of the large intestine (HP:0002037) | 3.47760922 |
19 | Chronic otitis media (HP:0000389) | 3.45378514 |
20 | IgM deficiency (HP:0002850) | 3.44675252 |
21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.41723620 |
22 | Keratoconjunctivitis sicca (HP:0001097) | 3.30550894 |
23 | Gingivitis (HP:0000230) | 3.29980253 |
24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29731820 |
25 | Cellulitis (HP:0100658) | 3.27259671 |
26 | Stomatitis (HP:0010280) | 3.25380402 |
27 | Urticaria (HP:0001025) | 3.24596074 |
28 | Gastrointestinal inflammation (HP:0004386) | 3.23240535 |
29 | Myositis (HP:0100614) | 3.22425999 |
30 | Colitis (HP:0002583) | 3.22156059 |
31 | Vasculitis (HP:0002633) | 3.21627798 |
32 | Recurrent bronchitis (HP:0002837) | 3.12399835 |
33 | Keratoconjunctivitis (HP:0001096) | 3.02153699 |
34 | Thyroiditis (HP:0100646) | 2.96927811 |
35 | Abnormality of macrophages (HP:0004311) | 2.95126029 |
36 | Chronic diarrhea (HP:0002028) | 2.93427453 |
37 | T lymphocytopenia (HP:0005403) | 2.93308553 |
38 | Autoimmune thrombocytopenia (HP:0001973) | 2.88960426 |
39 | Abnormality of T cell number (HP:0011839) | 2.88744768 |
40 | Eosinophilia (HP:0001880) | 2.83896777 |
41 | Lymphopenia (HP:0001888) | 2.81311507 |
42 | Hypochromic microcytic anemia (HP:0004840) | 2.72391339 |
43 | Gastrointestinal stroma tumor (HP:0100723) | 2.70622335 |
44 | Spontaneous hematomas (HP:0007420) | 2.70620516 |
45 | Hypochromic anemia (HP:0001931) | 2.70319197 |
46 | Retrobulbar optic neuritis (HP:0100654) | 2.70052909 |
47 | Optic neuritis (HP:0100653) | 2.70052909 |
48 | Vacuolated lymphocytes (HP:0001922) | 2.69880881 |
49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.68721780 |
50 | Osteomyelitis (HP:0002754) | 2.66893548 |
51 | Pustule (HP:0200039) | 2.65375492 |
52 | Leukocytosis (HP:0001974) | 2.65092321 |
53 | Abnormality of T cells (HP:0002843) | 2.64477745 |
54 | Systemic lupus erythematosus (HP:0002725) | 2.63533202 |
55 | Periodontitis (HP:0000704) | 2.62986193 |
56 | Episodic fever (HP:0001954) | 2.59285113 |
57 | Recurrent pneumonia (HP:0006532) | 2.59043815 |
58 | Prolonged bleeding time (HP:0003010) | 2.58748770 |
59 | Severe combined immunodeficiency (HP:0004430) | 2.57335891 |
60 | Petechiae (HP:0000967) | 2.56440542 |
61 | Recurrent sinusitis (HP:0011108) | 2.54227801 |
62 | Abnormality of B cell number (HP:0010975) | 2.54186922 |
63 | B lymphocytopenia (HP:0010976) | 2.54186922 |
64 | Increased IgM level (HP:0003496) | 2.53369497 |
65 | Orchitis (HP:0100796) | 2.51611103 |
66 | Abnormality of eosinophils (HP:0001879) | 2.47690954 |
67 | Granulocytopenia (HP:0001913) | 2.47348884 |
68 | Cheilitis (HP:0100825) | 2.44914414 |
69 | Pulmonary embolism (HP:0002204) | 2.44829960 |
70 | Pulmonary infiltrates (HP:0002113) | 2.44376968 |
71 | Abnormality of T cell physiology (HP:0011840) | 2.42405399 |
72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41504227 |
73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41504227 |
74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41504227 |
75 | Anorexia (HP:0002039) | 2.39326137 |
76 | Increased IgE level (HP:0003212) | 2.37357736 |
77 | Amyloidosis (HP:0011034) | 2.36822710 |
78 | Loss of speech (HP:0002371) | 2.33901777 |
79 | Chronic sinusitis (HP:0011109) | 2.33736040 |
80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.33323849 |
81 | Encephalitis (HP:0002383) | 2.28816952 |
82 | Hypergammaglobulinemia (HP:0010702) | 2.27493065 |
83 | Purpura (HP:0000979) | 2.25599694 |
84 | Glomerulonephritis (HP:0000099) | 2.25004406 |
85 | Sepsis (HP:0100806) | 2.18767065 |
86 | Combined immunodeficiency (HP:0005387) | 2.18541447 |
87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18208346 |
88 | Peritonitis (HP:0002586) | 2.18201664 |
89 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.17666647 |
90 | Emphysema (HP:0002097) | 2.17123585 |
91 | Abnormality of the pleura (HP:0002103) | 2.16751435 |
92 | Hepatosplenomegaly (HP:0001433) | 2.15653163 |
93 | IgA deficiency (HP:0002720) | 2.15415024 |
94 | IgG deficiency (HP:0004315) | 2.13381179 |
95 | Thoracic kyphosis (HP:0002942) | 2.12293398 |
96 | Dysostosis multiplex (HP:0000943) | 2.12098409 |
97 | Premature loss of primary teeth (HP:0006323) | 2.11458629 |
98 | Hemoptysis (HP:0002105) | 2.11382976 |
99 | Gangrene (HP:0100758) | 2.11131788 |
100 | Chromsome breakage (HP:0040012) | 2.10939555 |
101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.10675457 |
102 | Increased serum ferritin (HP:0003281) | 2.09574870 |
103 | Gingival bleeding (HP:0000225) | 2.06842445 |
104 | Microcytic anemia (HP:0001935) | 2.06401814 |
105 | Nasal polyposis (HP:0100582) | 2.05460156 |
106 | Slow saccadic eye movements (HP:0000514) | 2.04653194 |
107 | Viral hepatitis (HP:0006562) | 2.03811859 |
108 | Epistaxis (HP:0000421) | 2.02878219 |
109 | Abnormality of the peritoneum (HP:0002585) | 2.02425018 |
110 | Restrictive lung disease (HP:0002091) | 2.01517020 |
111 | Papilloma (HP:0012740) | 2.00956863 |
112 | Verrucae (HP:0200043) | 2.00956863 |
113 | Glomerulopathy (HP:0100820) | 1.99932992 |
114 | Prostate neoplasm (HP:0100787) | 1.96154491 |
115 | Disinhibition (HP:0000734) | 1.94005247 |
116 | Leukopenia (HP:0001882) | 1.93502896 |
117 | Lymphoma (HP:0002665) | 1.92342292 |
118 | Metaphyseal cupping (HP:0003021) | 1.91658719 |
119 | Abnormality of the endocardium (HP:0004306) | 1.91629798 |
120 | Arterial thrombosis (HP:0004420) | 1.89968078 |
121 | Autoimmune hemolytic anemia (HP:0001890) | 1.89219232 |
122 | Chest pain (HP:0100749) | 1.88907506 |
123 | Abnormality of the prostate (HP:0008775) | 1.88668376 |
124 | Abnormality of homocysteine metabolism (HP:0010919) | 1.88201137 |
125 | Homocystinuria (HP:0002156) | 1.88201137 |
126 | Increased cerebral lipofuscin (HP:0011813) | 1.88150604 |
127 | Hematochezia (HP:0002573) | 1.87221745 |
128 | Skin ulcer (HP:0200042) | 1.86557182 |
129 | Absent frontal sinuses (HP:0002688) | 1.86399186 |
130 | Abnormality of the thoracic spine (HP:0100711) | 1.85447807 |
131 | Basal ganglia calcification (HP:0002135) | 1.84271425 |
132 | Abnormality of DNA repair (HP:0003254) | 1.83548584 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.60595319 |
2 | IRAK4 | 3.71002148 |
3 | IRAK3 | 3.03086882 |
4 | TXK | 3.02214446 |
5 | BLK | 2.96854588 |
6 | TYK2 | 2.95128338 |
7 | MAP3K14 | 2.94822774 |
8 | PRPF4B | 2.87772124 |
9 | JAK3 | 2.24907043 |
10 | SIK2 | 2.20317689 |
11 | RIPK4 | 2.20171134 |
12 | IKBKE | 2.14651507 |
13 | JAK1 | 2.09974427 |
14 | KIT | 2.00675066 |
15 | ZAP70 | 1.94796833 |
16 | BTK | 1.93131218 |
17 | CSF1R | 1.81436490 |
18 | HCK | 1.80518592 |
19 | TBK1 | 1.76917357 |
20 | TEC | 1.75789927 |
21 | TAOK1 | 1.75402795 |
22 | FES | 1.73686698 |
23 | MAP3K13 | 1.70162878 |
24 | STK10 | 1.70033143 |
25 | SYK | 1.70020593 |
26 | MAP3K11 | 1.68031502 |
27 | ITK | 1.64005297 |
28 | TGFBR2 | 1.63191579 |
29 | IKBKB | 1.62899664 |
30 | MAP3K3 | 1.61507812 |
31 | CLK1 | 1.56144732 |
32 | CSK | 1.54026064 |
33 | LCK | 1.50996993 |
34 | CAMK1G | 1.48990843 |
35 | TAOK3 | 1.48274874 |
36 | CAMK1D | 1.46843593 |
37 | TRIB3 | 1.45620890 |
38 | CDK12 | 1.40266374 |
39 | GRK6 | 1.30723171 |
40 | EPHB1 | 1.30363766 |
41 | LYN | 1.25457065 |
42 | MAP3K1 | 1.21358520 |
43 | CHUK | 1.19849239 |
44 | MAP3K10 | 1.16664914 |
45 | SMG1 | 1.13559270 |
46 | TAOK2 | 1.11685064 |
47 | MARK3 | 1.09889761 |
48 | MATK | 1.07106265 |
49 | TNIK | 1.05801175 |
50 | ERN1 | 1.03816489 |
51 | FGFR4 | 1.03783194 |
52 | KSR2 | 1.02065356 |
53 | TESK2 | 1.01604312 |
54 | TNK2 | 1.00466985 |
55 | FGFR3 | 0.98820327 |
56 | SIK3 | 0.98101222 |
57 | SIK1 | 0.95175206 |
58 | PIM1 | 0.87536529 |
59 | BRD4 | 0.85428255 |
60 | NLK | 0.84570685 |
61 | IRAK2 | 0.84256035 |
62 | PDK1 | 0.83589344 |
63 | MAP2K3 | 0.81223857 |
64 | YES1 | 0.80986585 |
65 | MAP3K6 | 0.80306200 |
66 | INSRR | 0.75875467 |
67 | EEF2K | 0.75238879 |
68 | PRKCQ | 0.74667137 |
69 | TRPM7 | 0.73060921 |
70 | EIF2AK2 | 0.71844568 |
71 | PDPK1 | 0.71794132 |
72 | BMPR2 | 0.71415536 |
73 | RPS6KA4 | 0.71096132 |
74 | IRAK1 | 0.69251417 |
75 | SGK3 | 0.69242934 |
76 | FGR | 0.67409497 |
77 | JAK2 | 0.65898223 |
78 | NUAK1 | 0.63634535 |
79 | CDK19 | 0.60734395 |
80 | HIPK2 | 0.60277429 |
81 | STK4 | 0.60180457 |
82 | MARK2 | 0.59294550 |
83 | PRKD2 | 0.56230385 |
84 | GRK7 | 0.54081111 |
85 | ZAK | 0.52031974 |
86 | DYRK1B | 0.51088883 |
87 | CAMKK1 | 0.50775923 |
88 | RPS6KC1 | 0.50650338 |
89 | RPS6KL1 | 0.50650338 |
90 | CDK9 | 0.49421752 |
91 | PTK6 | 0.48863001 |
92 | NEK9 | 0.48718346 |
93 | SGK2 | 0.48382792 |
94 | RET | 0.48367102 |
95 | ABL1 | 0.48244981 |
96 | PRKCH | 0.47174997 |
97 | MAP3K5 | 0.46063174 |
98 | PKN1 | 0.45183390 |
99 | EPHA3 | 0.40438570 |
100 | PIK3CG | 0.40349426 |
101 | MAPK7 | 0.40190516 |
102 | FYN | 0.39791414 |
103 | MAP3K7 | 0.39565350 |
104 | MAPK12 | 0.39390153 |
105 | STK11 | 0.37396365 |
106 | RPS6KA6 | 0.36023420 |
107 | PRKAA2 | 0.35938793 |
108 | MAPKAPK2 | 0.34883891 |
109 | ATR | 0.34812632 |
110 | LRRK2 | 0.34708249 |
111 | CAMK4 | 0.33446246 |
112 | PKN2 | 0.33044804 |
113 | TTN | 0.32907473 |
114 | DMPK | 0.32401955 |
115 | EGFR | 0.32167803 |
116 | MAP2K4 | 0.31892698 |
117 | PTK2B | 0.31560145 |
118 | CDK4 | 0.31508962 |
119 | MAP3K8 | 0.31420728 |
120 | CDK6 | 0.31305916 |
121 | INSR | 0.30535110 |
122 | MAPK4 | 0.30437613 |
123 | RPS6KA2 | 0.30080114 |
124 | CAMKK2 | 0.30004211 |
125 | MKNK2 | 0.29900872 |
126 | CDC42BPA | 0.29759160 |
127 | MAP2K6 | 0.29688749 |
128 | ICK | 0.28063455 |
129 | IGF1R | 0.27970395 |
130 | PDGFRB | 0.27913464 |
131 | GRK1 | 0.27863882 |
132 | MOS | 0.27352968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.31021113 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.72688978 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.68787105 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54901017 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46580799 |
6 | Measles_Homo sapiens_hsa05162 | 2.20391171 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08136566 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.06894949 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04183892 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98829615 |
11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96911431 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94897445 |
13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.93828104 |
14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87096712 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80633785 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68093154 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66065058 |
18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57447881 |
19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55329475 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.53939586 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53078241 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52151313 |
23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51093324 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49292138 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47880319 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.47205865 |
27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45668620 |
28 | Allograft rejection_Homo sapiens_hsa05330 | 1.44786030 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.40796307 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40035898 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37276985 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28840015 |
33 | Malaria_Homo sapiens_hsa05144 | 1.28775621 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19422500 |
35 | Hepatitis B_Homo sapiens_hsa05161 | 1.18059520 |
36 | Lysosome_Homo sapiens_hsa04142 | 1.17392124 |
37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16683336 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15994191 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.15456301 |
40 | Asthma_Homo sapiens_hsa05310 | 1.13081849 |
41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08151945 |
42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05045823 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.03898231 |
44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03255552 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01947516 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01840545 |
47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96911560 |
48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96446588 |
49 | Platelet activation_Homo sapiens_hsa04611 | 0.94188829 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 0.92964227 |
51 | Legionellosis_Homo sapiens_hsa05134 | 0.92146346 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 0.90520092 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86913082 |
54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85736694 |
55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85161928 |
56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84041422 |
57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83075556 |
58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81483651 |
59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80485327 |
60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79470403 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.70615360 |
62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69692262 |
63 | Phagosome_Homo sapiens_hsa04145 | 0.69605070 |
64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68742430 |
65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68666665 |
66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68386260 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68128110 |
68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65875807 |
69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65532405 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63210796 |
71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62128158 |
72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60369235 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59083492 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59017054 |
75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57755196 |
76 | Amoebiasis_Homo sapiens_hsa05146 | 0.57390896 |
77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57368873 |
78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57268113 |
79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56594313 |
80 | ABC transporters_Homo sapiens_hsa02010 | 0.55833572 |
81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55044344 |
82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54913692 |
83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54413103 |
84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53241050 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52684218 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51502052 |
87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50448910 |
88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49717228 |
89 | Homologous recombination_Homo sapiens_hsa03440 | 0.48444725 |
90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48214813 |
91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47781623 |
92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47433576 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.46153715 |
94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44972135 |
95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44023711 |
96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43755175 |
97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43432524 |
98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43385083 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.43134387 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43028711 |
101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42545337 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41798029 |
103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41703791 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41295771 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.40614963 |
106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39118755 |
107 | Base excision repair_Homo sapiens_hsa03410 | 0.38151656 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36214152 |
109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34102430 |
110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33162953 |
111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32599232 |
112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32389577 |
113 | Glioma_Homo sapiens_hsa05214 | 0.31843175 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.31747508 |
115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31440452 |
116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31438811 |
117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30473682 |